
<p>miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC)</p>
Author(s) -
Zhang Hong-yu,
Jin Ma
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s262442
Subject(s) - downregulation and upregulation , cancer research , microrna , biomarker , cell growth , medicine , proportional hazards model , cancer , oncology , hepatocellular carcinoma , cell , biology , gene , biochemistry , genetics
miRNA-105 has been reported in a vast number of malignancies, including hepatocellular carcinoma and colorectal, esophageal, breast and non-small lung cancers. Still, the biological role of miR-105 remains mostly uncovered in oral squamous cell carcinoma (OSCC).